First Molecular Detection and Epidemiological Analysis of Equine Influenza Virus in Two Regions of Colombia, 2020–2023
Juliana Gonzalez-Obando,
Angélica Zuluaga-Cabrera,
Isabel Moreno,
Jaime Úsuga,
Karl Ciuderis,
Jorge E. Forero,
Andrés Diaz,
Carlos Rojas-Arbeláez,
Juan P. Hernández-Ortiz,
Julian Ruiz-Saenz
Affiliations
Juliana Gonzalez-Obando
Grupo de Investigación en Ciencias Animales—GRICA, Facultad de Medicina Veterinaria y Zootecnia, Universidad Cooperativa de Colombia, Bucaramanga 680002, Colombia
Angélica Zuluaga-Cabrera
Grupo de Investigación GISCA, Facultad de Medicina Veterinaria y Zootecnia, Fundación Universitaria Vision de las Américas, Medellín 050031, Colombia
Isabel Moreno
GHI One Health Colombia, Universidad Nacional de Colombia, Medellín 050036, Colombia
Jaime Úsuga
GHI One Health Colombia, Universidad Nacional de Colombia, Medellín 050036, Colombia
Karl Ciuderis
GHI One Health Colombia, Universidad Nacional de Colombia, Medellín 050036, Colombia
Jorge E. Forero
Grupo de Investigación en Microbiología Ambiental, Escuela de Microbiología, Universidad de Antioquia, Medellín 050010, Colombia
Andrés Diaz
Pig Improvement Company Hendersonville, Hendersonville, TN 37075, USA
Carlos Rojas-Arbeláez
Grupo de Epidemiología, Universidad de Antioquia, Medellín 050010, Colombia
Juan P. Hernández-Ortiz
GHI One Health Colombia, Universidad Nacional de Colombia, Medellín 050036, Colombia
Julian Ruiz-Saenz
Grupo de Investigación en Ciencias Animales—GRICA, Facultad de Medicina Veterinaria y Zootecnia, Universidad Cooperativa de Colombia, Bucaramanga 680002, Colombia
Equine influenza is a viral disease caused by the equine influenza virus (EIV), and according to the WOAH, it is mandatory to report these infections. In Latin America and Colombia, EIV risk factors have not been analyzed. The objective of this research is to perform an epidemiological and molecular analysis of the EIV in horses with respiratory symptoms from 2020 to 2023 in Colombia. Molecular EIV detection was performed using RT–qPCR and nanopore sequencing. A risk analysis was also performed via the GEE method. A total of 188 equines with EIV respiratory symptoms were recruited. The positivity rate was 33.5%. The descriptive analysis showed that only 12.8% of the horses were vaccinated, and measures such as the quarantine and isolation of symptomatic animals accounted for 91.5% and 88.8%, respectively. The variables associated with the EIV were the non-isolation of positive individuals (OR = 8.16, 95% CI (1.52–43.67), p = 0.014) and sharing space with poultry (OR = 2.16, 95% CI (1.09–4.26), p = 0.027). In conclusion, this is the first EIV investigation in symptomatic horses in Colombia, highlighting the presence of the virus in the country and the need to improve preventive and control measures.